Breaking News

Hoth Therapeutics, Wise Systems Partner to Leverage AI for Drug Discovery

Will leverage the BioNeMo AI platform of Nvidia to build and integrate generative AI applications across the drug discovery pipeline.

Author Image

By: Charlie Sternberg

Associate Editor

Hoth Therapeutics Inc., a patient-focused biopharmaceutical company, has entered into a joint development agreement with Wise Systems International SRL to leverage artificial intelligence utilizing the BioNeMo AI platform of Nvidia.    BioNeMo enables researchers and developers to build and integrate state-of-the-art generative AI applications across the entire drug discovery pipeline—from target identification to lead optimization—with AI workflows. With the help of SRL, Hoth Therapeutics wil...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters